NFKB1 and cancer: FUT175 is also known to inhibit the chemotherapy-induced translocation of NF-κB to nuclear in several cancer cell lines including pancreatic, gastric and gallbladder cancer cells [25,26,27], indicating that pre-treatment of FUT175 can suppress the induction of NF-κB in various cell lines which were treated with anti-cancer therapy.